Unosource Pharma Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2013.
2013 Delhi, Delhi, India Active
Last Updated:
Access Report
About Unosource Pharma Limited

Unosource Pharma Limited, a active public limited company, was established on 18 December 2013 in Delhi, Delhi, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24233DL2013PLC262364. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹18.02 Cr.

It upholds a compliant status. Employing 41 professional, Its leadership includes Manju Bist (Director), Rama Shanker (Director), Manmohan Singh (Director). Past directors included Mohammad Shahbaz Alam, Pankaj Kumar Jha, Hema Arora. It holds ₹20.00 Cr open charges and ₹7.00 Cr settled loans. Its latest AGM occurred on 15 June 2025, with the balance sheet filed on 31 March 2025. It is based at 305, Third Floor, C-Block, Plot No. 5 Mohan Place, Saraswati Vihar, Delhi, Delhi, 110034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233DL2013PLC262364

  • Registration Number

    262364

  • Incorporation Date

    18 December 2013

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹18.02 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 18.02 Cr
  • Company Age 12 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 20.00 Cr
  • Satisfied Charges ₹ 7.00 Cr
  • Revenue Growth **** 24.87%
  • Profit Growth **** -24.91%
  • Ebitda **** 85.98%
  • Net Worth 37.35%
  • Total Assets **** 4.32%
Company report

Unosource Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Unosource Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Unosource Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Manju Bist Director 20 Aug 2024 Current
Rama Shanker Director 29 May 2024 Current
Manmohan Singh Director 15 Jun 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2020 Past
Pramod Abcsdd Director 10 Jul 2014 Past
Pramod Abcsdd Director 10 Jul 2014 Past
Pramod Abcsdd Additional Director 12 Mar 2015 Past
Pramod Abcsdd Additional Director 29 Sep 2020 Past
Pramod Abcsdd Additional Director 10 Aug 2017 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Unosource Pharma.

Unosource Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 24.87% increase. The company also saw a substantial fall in profitability, with a 24.91% decrease in profit. The company's net worth Soared by an impressive increase of 37.35%.

Unosource Pharma revenue growth over time
Unosource Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 24.87%
*******
*******
*******
*******
Revenue from Operations
*******
 26.65%
*******
*******
*******
*******
Total Assets
*******
 4.32%
*******
*******
*******
*******
Profit or Loss
*******
 -24.91%
*******
*******
*******
*******
Net Worth
*******
 37.35%
*******
*******
*******
*******
EBITDA
*******
 85.98%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Unosource Pharma?

In 2024, Unosource Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹200,000,000.00

Satisfied Charges

₹70,000,000.00

Charges Breakdown by Lending Institutions
  • Citi Bank N.A. : 5.00 Cr
  • The Hongkong And Shanghai Banking Corporation Limited : 5.00 Cr
  • Others : 5.00 Cr
  • Hdfc Bank Limited : 5.00 Cr
Latest Charge Details
Date Lender Amount Status
17 Sep 2025 Hdfc Bank Limited ₹5.00 Cr Open
11 Sep 2023 Others ₹5.00 Cr Open
14 Jul 2023 The Hongkong And Shanghai Banking Corporation Limited ₹5.00 Cr Open
16 Dec 2022 Citi Bank N.A. ₹5.00 Cr Open
02 Apr 2018 Yes Bank Limited ₹5.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Unosource Pharma?

Unosource Pharma has a workforce of 41 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Unosource Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unosource Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Unosource Pharma
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101162760 was registered on 17 Sep 2025. was documented.

  • Charges

    The activity A charge with Citi Bank N.A. of Rs. 5.00 Cr registered on 16 Dec 2022 with Charge ID 100663687 was modified on 28 Jul 2025. was completed.

  • Annual General Meeting

    The activity Unosource Pharma Limited last Annual general meeting of members was held on 15 Jun 2025 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with The Hongkong And Shanghai Banking Corporation Limited of Rs. 5.00 Cr registered on 14 Jul 2023 with Charge ID 100749854 was modified on 22 May 2025. was documented.

  • Balance Sheet

    Unosource Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Manju Bist was appointed as a Director was appointed as a Director on 20 Aug 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Unosource Pharma Limited?

The CIN of Unosource Pharma Limited is U24233DL2013PLC262364.

Where is Unosource Pharma Limited headquartered?

Unosource Pharma Limited is headquartered at 305, Third Floor, C-Block, Plot No. 5 Mohan Place, Saraswati Vihar, Delhi, Delhi, 110034.

When was Unosource Pharma Limited incorporated?

Unosource Pharma Limited was incorporated on 18 December 2013.

Who are the current directors of Unosource Pharma Limited?

The current directors of Unosource Pharma Limited are

What is the primary industry of Unosource Pharma Limited?

The primary industry of Unosource Pharma Limited is Hospital And Medical Care.

Is Unosource Pharma Limited a listed company?

Unosource Pharma Limited is unlisted.

What is the capital structure of Unosource Pharma Limited?

The authorized capital of Unosource Pharma Limited is ₹20.00 Cr, and the paid-up capital is ₹18.02 Cr.

What is the compliance status of Unosource Pharma Limited?

The compliance status of Unosource Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available